title: [Clinico-pathogenetic aspects of peptic ulcer therapy].
abstract: Peptic ulcer therapy should be combined and take into consideration possible risk factors and the clinicopathogenetic aspects of the disease. The first stage involves the treatment of a relapse. It is to be carried out at hospital and to include protective regimen, diet, and agents that normalize disorders of nervous regulation, of secretory and motor functions of the stomach, endocrine shifts, drugs that relieve microcirculatory disorders and inflammatory phenomena, contributing to ulcer healing. The second stage involves reinforcement of the treatment results after the patients' discharge from hospital. The third stage involves carrying out of antirelapse measures. Such a principle of the patients' management enables reduction of the time of their stay at hospital by 6.2 days, increase of the percentage of ulcer healing from 76 to 94, reduction of the number of relapses by 2.5 times, decrease of the temporary disability by 3.4 times, and elimination of the disease complications.
authors.forename: V V
authors.initials: VV
authors.lastname: Chernin
mesh_terms: D006801:Humans; D010437:Peptic Ulcer / Q000209:etiology / Q000628:therapy*; D012008:Recurrence; D012307:Risk Factors
vernacular_title: Kliniko-patogeneticheskie aspekty terapii iazvennoĭ bolezni.